Human Reproduction, Vol. 17, No. 9, 2481-2482,
September 2002
© 2002 European Society of Human Reproduction and Embryology
Metformin and FSH for induction of ovulation in women with polycystic ovarian syndrome
Department Obstetrics and Gynecology, University of Siena, Policlinico Le Scotte, 53100 Siena, Italy E-mail: deleo@unisi.it
| The first 10% of the full text of this article appears below. |
| Introduction |
|---|
Dear Editor,
We read with interest the recent study by Yarali and colleagues in which the authors demonstrated in a randomized, placebo-controlled study, that metformin administration is not associated with modification in ovarian response to recombinant (r)FSH treatment (Yarali et al., 2002
).
A total of 32 polycystic ovarian syndrome (PCOS) patients were randomized to metformin (n = 16) or placebo (n =
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
A.E. Nieuwenhuis-Ruifrok, W.K.H. Kuchenbecker, A. Hoek, P. Middleton, and R.J. Norman Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis Hum. Reprod. Update, January 1, 2009; 15(1): 57 - 68. [Abstract] [Full Text] [PDF] |
||||
